Looking Toward the Future: How Preclinical Alzheimer’s Disease Biomarker Disclosures Impact Society

Brain-Gut Photobiomodulation: Preclinical and Clinical Studies for Alzheimer’s Disease.Подробнее

2/12/2021: Disclosing Amyloid Biomarker Results in Preclinical Alzheimer's DiseaseПодробнее

Alzheimer’s Disease 2024: The Role of BiomarkersПодробнее

Alzheimer’s Disease Biomarker Testing and DisclosureПодробнее

Dementia education I The who, what, where and when of Alzheimer’s disease biomarker testingПодробнее

Under the Hood: Tracking Preclinical Alzheimer's Disease with BiomarkersПодробнее

Dr Chris Kalafatis - Biomarkers in Alzheimer's Disease current use and future possibilitiesПодробнее

The future of diagnostics in the evolving Alzheimer’s disease care landscapeПодробнее

What Advances in Blood Biomarker Research Could Mean for the Future of Alzheimer's DiseaseПодробнее

Biomarkers for Alzheimer’s disease in a preclinical settingПодробнее

Current and Future Biomarker Testing Landscape in Alzheimer’s DiseaseПодробнее

Looking to the Future of Alzheimer's TreatmentПодробнее

Multiplex Immunoassay Detection of Alzheimer's Disease BiomarkerПодробнее

The Case for Disclosing Biomarker Results to Alzheimer’s Research ParticipantsПодробнее

Applying Fluid Biomarkers to Facilitate the Accurate Neuropathological Diagnosis of ADПодробнее

ANA Investigates Biomarkers for Alzheimer's DiseaseПодробнее

1/24/2020: Brain and Cognitive Changes in Pre-Symptomatic Alzheimer’s Disease: New FindingsПодробнее

E175 - The PsychopharmaStahlogy Show: Alzheimer’s Disease: Biomarkers and Treatments that Target ...Подробнее

Biomarkers for Alzheimer’s disease: past, present and futureПодробнее

Seeking the Biomarkers of Alzheimer's Disease - On Our MindПодробнее